Full-Time

Human Resources Manager

Posted on 7/2/2026

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

Compensation Overview

$100.7k - $155.1k/yr

Washington, USA

Remote

Bachelor's

Category
People & HR (1)
Required Skills
Workday HRIS
Human Resources Information System (HRIS)
OSHA
HIPAA

Get referred to Cencora

See people who can refer or advise you

Requirements
  • A bachelor's degree in Human Resources, Business Administration, Healthcare Administration, or a related field is required.
  • Three to five years of experience in Human Resources is required.
  • Experience supporting multi-site organizations is required.
  • Deep knowledge of Washington State and federal employment laws is required.
  • Experience managing and developing HR teams is required.
  • Strong consultative, facilitation, communication, and presentation skills are required.
  • Strong analytical and problem-solving skills are required.
  • Proficiency with HRIS platforms such as ADP, Paylocity, UKG, Workday, or similar is required.
Responsibilities
  • Partner with physician leadership, the Practice Administrator/COO, and clinic managers to develop and implement people strategies and workforce plans aligned with business objectives.
  • Advise senior leaders on talent growth strategies and technical capability pipelines.
  • Provide coaching to business leaders to deliver on their people goals.
  • Lead the design of structures that improve individual and organizational performance.
  • Serve as the primary HR liaison between Pacific Northwest Retina and RCA/Cencora's corporate HR team and organizational capabilities.
  • Coordinate centralized programs including benefits, HRIS/payroll, compensation benchmarking, and shared HR policies.
  • Partner with Centers of Expertise to drive performance management, learning and development, succession planning, and key HR processes.
  • Lead implementation of standardized HR processes aligned with RCA/Cencora frameworks.
  • Participate in the Cencora acquisition integration workstream by aligning local HR policies, benefits, and compensation with Cencora standards.
  • Communicate changes to associates with clarity, empathy, and transparency.
  • Support cultural integration while preserving the practice's physician-led identity.
  • Ensure continuity of associate experience during system migrations and organizational restructuring.
  • Enable change-management planning and activities, particularly for the Cencora transition.
  • Champion adoption of communication strategies that keep associates informed and engaged during periods of change.
  • Manage highly complex associate-relations issues that may have significant business impact.
  • Ensure successful resolution of labor-relations issues in partnership with the Employee Relations Center of Expertise.
  • Conduct investigations and manage sensitive workplace matters with discretion.
  • Evaluate and manage compensation structures, benefits programs, and incentive plans in partnership with RCA and Cencora Centers of Expertise.
  • Lead local execution of benefits enrollment and support transition to Cencora platforms.
  • Ensure compliance with Washington State and federal employment laws, including FMLA, ADA, FLSA, HIPAA, OSHA, Washington Paid Family and Medical Leave, WA Cares Fund, and applicable municipal labor laws.
  • Align local policies with RCA and Cencora enterprise standards.
  • Maintain and update the employee handbook and oversee workers' compensation and leave administration.
  • Manage day-to-day HR operations using RCA's centralized HRIS, payroll, and timekeeping platforms.
  • Produce HR analytics and reporting for practice leadership and RCA/Cencora stakeholders.
  • Support HRIS and payroll system migrations during the Cencora integration.
  • Lead the HR workstream for new clinic openings, including staffing plans, recruitment, and onboarding.
  • Support integration of team members from acquired or merged practices.
Desired Qualifications
  • Experience supporting healthcare providers or practices.
  • Experience in a physician clinic, medical group, or specialty practice setting.
  • Experience within a management services organization, dental service organization, or private-equity-backed healthcare model.
  • Experience supporting organizations through mergers, acquisitions, or corporate integrations.
  • Experience with ophthalmology, retina, or specialty surgical practices.
  • Familiarity with ophthalmic clinical roles and credentialing requirements.

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Get referred to Cencora

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 results raised fiscal 2026 EPS guidance to $17.75-$17.95.
  • July 31, 2026 credit facility expansion to $7 billion strengthens liquidity through 2031.
  • Specialty medicine demand and GLP-1 volume lifted third-quarter revenue to $84.75 billion.

What critics are saying

  • $4.2 billion opioid liability remains outstanding as of June 30, 2026.
  • The 2024 Cencora data breach settlement keeps cybersecurity and trust damage visible through 2026.
  • Specialty and GLP-1 concentration creates margin pressure if manufacturer pricing or mix shifts again.

What makes Cencora unique

  • Cencora owns irreplaceable pharmaceutical distribution scale across U.S. Healthcare and International networks.
  • February 2026 OneOncology deepens specialty oncology workflows and physician practice integration.
  • Nucleus inventory tooling embeds Cencora inside specialty practices' medication and billing operations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Company News

MarketScreener
Aug 5th, 2026
Cencora boosts credit facility to $7B, extends maturity to 2031

Cencora and its subsidiary Innomar Strategies have amended their credit agreement, increasing their multi-currency revolving credit facility from $5.5 billion to $7.0 billion. The facility's maturity date has been extended to July 2031. Interest rates on borrowings range from 69.5 to 110 basis points over various term rates, depending on Cencora's public debt ratings. The agreement includes covenants such as a maximum financial leverage ratio. Separately, on 31 July 2026, Cencora amended its receivables securitisation facility, reducing it from $1.5 billion to $1.0 billion whilst increasing the accordion feature from $500 million to $1.0 billion. This gives the company the option to expand commitments by up to $1.0 billion, subject to bank approval.

Yahoo Finance
Aug 1st, 2026
Cencora Q3 earnings preview: analysts expect $4.37 EPS on $84.89B revenue

Wall Street analysts expect Cencora to report quarterly earnings of $4.37 per share, marking a 9.3% year-over-year increase. Revenues are projected to reach $84.89 billion, up 5.2% from the same quarter last year. Over the past 30 days, the consensus earnings per share estimate has been revised upward by 1.3%. Analysts forecast revenue from Total US Healthcare Solutions at $75 billion, representing 2.9% year-over-year growth. International Healthcare Solutions revenue is expected to remain flat at $7.79 billion. Operating income projections show US Healthcare Solutions at $940.87 million and International Healthcare Solutions at $158.45 million. Cencora shares have risen 5.3% over the past month and hold a Zacks Rank of 2, indicating expected outperformance versus the broader market.

Yahoo Finance
Jul 13th, 2026
CVS Health leads Q1 health insurance earnings as Cencora misses revenue estimates by 3.9%

CVS Health led health insurance providers in Q1, with revenues of $100.4 billion, up 6.2% year on year and beating analyst expectations by 6.3%. The company exceeded full-year EPS guidance estimates. The 12 health insurance provider stocks tracked reported strong Q1 results overall. Revenues beat consensus estimates by 1.4%, whilst next quarter's guidance was in line. Share prices rose 37.4% on average following the earnings announcements. Cencora performed weakest amongst peers, reporting revenues of $78.36 billion, up 3.8% year on year. This fell short of analyst expectations by 3.9%. The stock has remained flat since reporting and currently trades at $303.53. The industry faces tailwinds from an ageing population and improved data analytics, but regulatory scrutiny on pricing and medical cost inflation may impact margins.

Yahoo Finance
Jun 28th, 2026
Cencora launches Nucleus pilot and appoints ex-Verizon executive as CHRO

Cencora has launched a multi-site pilot of its upgraded Nucleus inventory management solution for specialty physician practices, aiming to improve medication workflow efficiency and inventory visibility. The company has also appointed Samantha Hammock, formerly of Verizon, as chief human resources officer, succeeding Silvana Battaglia. The company's stock trades at $286.13, approximately 18% below the $351 analyst consensus target. Cencora has posted mixed returns, gaining 5.3% over the past week and 6.2% over the past month, whilst declining 15.6% year to date. A key risk flagged by analysts is that debt is not well covered by operating cash flow. Investors will monitor adoption feedback from pilot sites and how the leadership changes affect the company's specialty care operations.

Business Wire
Jun 17th, 2026
Cencora pilots next-gen Nucleus® inventory solution across 20+ specialty physician practices

Cencora has launched a multi-site pilot of its enhanced Nucleus inventory management solution across more than 20 specialty physician practice sites. The updated platform combines redesigned physical infrastructure with improved software to help practices manage complex medication workflows more efficiently. Developed with input from customer advisory boards and care providers, the enhanced solution features a modular cabinet design, larger integrated touchscreen, built-in workspace improvements and a unified interface designed to reduce training time. The system provides real-time inventory tracking, demand forecasting and automated billing support. The pilot will evaluate system performance across different practice settings. Pending outcomes, Cencora expects to begin scaling production and installation later this year, with expanded availability planned for existing and new customers.

INACTIVE